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Our previous data indicated that C3, its bioactive pro-
duct iC3b, and the iC3b ligand CD11b are critical for
ultraviolet-induced immunosuppression. We thus hy-
pothesized that iC3b is an important skin-based factor
regulating CD11bþ monocytic cell function in the
acute post-ultraviolet period. Although monocytic cell
migration peaked at 1^3 d after ultraviolet exposure of
skin, dermal CD1c dendritic cells underwent a rapid
and prolonged depletion that did not recover until day
7. Because ultraviolet-induced iC3b deposits are reci-
procally maximal on day 3, but fade by day 7, we next
hypothesized that iC3b can be responsible for the delay
in di¡erentiation into dendritic cells of monocytic cells
migrating into ultraviolet-exposed skin. Analysis of
dermal cells derived from keratome biopsies suggested
that iC3b exposure could inhibit the development of
CD1cþ dermal cells. To model newly immigrating
blood monocytes entering ultraviolet-exposed, iC3b-
containing dermis, puri¢ed monocytes from human
blood were induced with granulocyte-macrophage col-
ony stimulating factor to generate a population of den-
dritic cell precursors expressing CD1c. Incubation with
iC3b markedly inhibited the appearance of CD1cþ cells
(po0.05) and induced CD1c^CD14þ cells. This inhibi-
tion was reversed by coincubation with an anti-CD11b
antibody that blocks the iC3b binding site. Other func-
tions associated with dendritic cell maturation were also
inhibited by iC3b, such as interleukin-12p70 production
as well as CD80 and CD40 expression. Restimulation of
monocytes for DC maturation revealed that iC3b
induced a temporary inhibition of DC di¡erentiation.
Thus, a human skin response in which iC3b is transiently
(3^7 d) generated in dermis, such as ultraviolet, can ar-
rest monocytic skin-in¢ltrating cells from undergoing
dendritic cell precursor di¡erentiation. Key words: ultra-
violet B/monocyte/cell di¡erentiation/complement/cytokine.
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U
ltraviolet B (UVB) induced immunosuppression
is an excellent test of skin integrity, requiring the
interplay of a number of biologic, structural, and
cell migration/di¡erentiation functions. UV has
been well known to play a substantial role in
modifying contact sensitivity, induction of microbial infections,
and development of skin cancer in humans. It has been demon-
strated that dermal Langerhans-cell-like dendritic cells (DC)
(Meunier et al, 1995) as well as epidermal Langerhans cells (Aberer
et al, 1981; Murphy et al, 1993) are depleted in UV-exposed skin, in
spite of expansion of a potential precursor population of newly
in¢ltrating monocytic cells, some of which are di¡erentiated to
interleukin-10 (IL-10) producing macrophages (Cooper et al,
1986; Meunier et al, 1995). The mechanism has not been clearly
elucidated, however. The changing populations of antigen-pre-
senting cells (APC) caused by UV radiation are involved in UV-
induced immunosuppression and tolerance. Our previous studies
have shown that in¢ltrating CD11bþ monocytic/macrophagic
cells are critical for induction of tolerance to dinitro£uoroben-
zene by UV-exposed epidermal cells (Hammerberg et al, 1994).
Complement receptor type 3 (CD11b/CD18), a member of the
b2 integrin family, is expressed on monocytes and macrophages,
polymorphonuclear leukocytes, and natural killer cells, and inter-
acts with a variety of ligands including iC3b (Beller et al, 1982),
intercellular adhesion molecule 1 (Diamond et al, 1990), ¢brino-
gen (Wright et al, 1988), and b glucan (Thornton et al, 1996). It is
known that iC3b can bind the I region of the a subunit of
monocytic CD11b.
Complement receptor type 3 is involved in several monocyte
and macrophage functions including phagocytosis, transmigra-
tion (Shang and Issekutz, 1998), and nitric oxide production
(Marth and Kelsall, 1997). In addition, we have reported that
iC3b and CD11b are critical for UV-mediated immunosuppres-
sion, because blockade of CD11b (Hammerberg et al, 1996) and
depletion of iC3b via soluble CR1 or C3 gene disruption
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(Hammerberg et al, 1998) in UV-exposed murine skin reversed
UV-induced immunosuppression. Deposition of iC3b can occur
in the skin 72 h after UV exposure, in contiguity with mono-
cytes/macrophages that in¢ltrate the skin at that time point.
Furthermore, binding of iC3b to b2 integrin on fresh monocytes
induced increased IL-10 production, but downregulated IL-12
production (Yoshida et al, 1998), consistent with the IL-10high
IL-12low cytokine pro¢le of the monocytic/macrophagic popula-
tion that in¢ltrates into UV-exposed skin (Kang et al, 1994; 1998).
It has been shown that in vitro blood monocytes can develop
into DC when incubated with cytokines such as granulocyte-
macrophage colony stimulating factor (GM-CSF), IL-4, tumor
necrosis factor a, and transforming growth factor b (Akagawa et
al, 1996; Pickl et al, 1996; Zhou and Tedder, 1996; Chapuis et al,
1997; Geissmann et al, 1998; Palucka et al, 1998). In addition, several
lines of indirect evidence support the concept that, in human
skin, in¢ltrating monocytes may di¡erentiate into DC. For ex-
ample, phenotypic transformation of dermal monocytic cells to
DC was observed in human skin after bone marrow transplanta-
tion (Murphy et al, 1986). Our previous work and that of others
have shown that CD1þ dermal DC in normal human skin ex-
press CD11b (Meunier et al, 1993; Gonzalez-Ramos et al, 1996),
and that some dermal DC are positive for CD14 and CD11b but
negative for CD1a (Nestle et al, 1993), indicating a transitional state
of di¡erentiation toward either CD14þ dermal macrophages or
CD1þ DC. Furthermore, in vitro, monocyte-derived DC express
a CD1cþ , CD11bþ, factor XIIIaþ phenotype (Grassi et al, 1998),
as does the dendritic APC population in human dermis (Meunier
et al, 1993; Nestle et al, 1993).
These ¢ndings raised the question of whether a distinct cell
di¡erentiation process a¡ects monocytic in¢ltrates in the UV-
modi¢ed micromilieu of the skin, in£uenced by the induced pre-
sence of iC3b (Yoshida et al, 1998) and cytokines such as GM-CSF
(Takashima and Bergstresser, 1996).We hypothesized that, under
the conditions of UV-exposed skin, iC3b and subsequent b2 in-
tegrin signaling not only induces IL-10high IL-12low macrophage
di¡erentiation, but also inhibits monocytic precursor di¡erentia-
tion toward DC.
In this study, we have investigated the temporal relationship
between iC3b deposition and CD1cþ cell depletion in the der-
mis, which is the primary site of in¢ltration and activation of
monocytic cells (Kang et al, 1998). The mechanism for delayed
reappearance of CD1cþ DC appears due, at least in part, to the
ability of iC3b to inhibit cytokine-induced maturation of mono-
cytes into early DC, including reduced expression of CD1c,
CD40, CD80, and IL-12, which are characteristic phenotypic
markers on mature DC.
MATERIALS AND METHODS
Subjects Healthy normal human adult volunteers on no systemic
medications participated in this study after institutional review board
approval of the protocol and informed consent. Punch biopsies and
keratomes were taken from normal buttock skin as controls or after a
single four minimal erythema dose of UVB irradiation from a bank of
Westinghouse FS20 bulbs (PSC Lamps, Pittsford, NY) at di¡erent time
points. This source has a continuous spectrum from 270 nm to 400 nm,
with the predominant UVB emission peaking at 314 nm (Davenport et al,
1999).
Immunostaining microscopy studies Six-micron frozen sections of
biopsies of normal and UVB-irradiated skin, after thawing and hydration
in phosphate-bu¡ered saline (PBS), were ¢rst blocked with 10% goat
serum/PBS. For human iC3b tissue staining, the slides were treated with
primary mouse monoclonal antibody for human iC3b (IgG2b, Quidel,
San Diego, CA), or its isotype control IgG2b (Sigma, St. Louis, MO), at a
dilution of 2 mg per ml in 10% goat serum/PBS for 1 h, washed with PBS
three times, followed by £uorescein isothiocyanate (FITC) conjugated goat
antimouse IgG2b secondary antibody (Caltag, Burlingame, CA). Slides
were viewed and photographed by £uorescence microscopy. For human
CD1c staining, the slides were treated with primary mouse monoclonal
antibody for human CD1c (IgG1, Immunotech, Westbrook, ME), or its
isotype control mouse IgG1 (Sigma), at a dilution of 1 mg per ml in 10%
goat serum/PBS for 1 h, washed with PBS three times, treated with biotin-
conjugated goat antimouse IgG1 secondary antibody (Caltag), then with
peroxidase-labeled streptavidin (Kirkegaad & Perry, Gaithersburg, MD)
for 30 min to 1 h, after washes, and detected with diaminobenzidine
(Sigma). Slides were viewed and photographed using a Zeiss Axiophot
microscope.
Preparation of dermal cell suspensions In addition to
immunostaining, dermal cells were also isolated and analyzed by £ow
cytometry. Keratomes were taken and placed in Dispase (Collaborative
Biomedical Products, Bedford, MA) for 20 min at 371C. After epidermis
was removed, dermal sheets were digested in collagenase, hyaluronidase,
and DNase (Sigma) for 3 h, ¢ltered through nylon mesh, and collected in
PBS containing 1% fetal bovine serum (FBS), as described previously (Tse
and Cooper, 1990; Kang et al, 1998). Dermal cell suspensions were placed
in RPMI 1640 (Life Technologies, Grand Island, NY) supplemented with
10% FBS (HyClone, Logan, UT) and penicillin/streptomycin (Life
Technologies) overnight at 371C before the following experiments.
Isolation of human blood monocytes Peripheral blood mononuclear
cells were obtained by centrifugation of heparinized fresh peripheral blood
with Ficoll gradients (1.077; Sigma). After incubation of peripheral blood
mononuclear cells in tissue culture dishes for 1 h at 371C, adherent cells
were harvested by 0.5 mM ethylenediamine tetraacetic acid in Hanks’
balanced salt solution (Life Technologies). Cells were treated with
blocking antibodies (FcgRII, anti-CD32, StemCell Technologies,
Vancouver, Canada) for 10 min on ice and incubated with antibody
mixture (anti-CD2, anti-CD3, anti-CD19, anti-CD56, and glycophorin A,
StemCell Technologies) for 15 min and with dextran^iron (StemCell
Technologies) for another 15 min at room temperature, followed by
adherence to a MACS separation column against a MidiMACS magnet
(Miltenyi Biotec, Auburn, CA). The purity of negatively selected
monocytes, as determined by £ow cytometry, was490%.
Preparation of IgM- and iC3b-coated sheep erythrocytes IgM-
coated sheep erythrocytes (EA) and IgM- plus iC3b-coated sheep
erythrocytes (EAiC3b) were prepared as previously described with some
modi¢cation (Sampson et al, 1991; Diamond et al, 1993; Yoshida et al, 1998).
Brie£y, EA were generated by incubating erythrocytes with antisheep
erythrocyte IgM for 15 min at 301C. EA were then incubated with C5-
de¢cient human serum (Sigma) for 1 h at 371C while rotating to convert
C3 to C3b and then iC3b, which is unable to cleave C5. Any residual C3b
was completely converted to iC3b by incubation with 1% fresh human
serum as a fresh source of factor H and I for 1 h at 371C (Sampson et al,
1991). It has been reported that on erythrocytes prepared with IgM and
whole serum almost all of the C3b is converted to iC3b, and very little, if
any, is degraded to C3d (Ross, 1980), which in any case is not recognized by
monocytes because they lack CR2. The presence of iC3b on erythrocytes
was veri¢ed by £ow cytometry using antihuman iC3b or its isotype
control IgG2b followed by FITC-conjugated goat antihuman IgG2b. The
expression of iC3b on EAiC3b was about 50-fold increased in £uorescence
intensity relative to EA.
Culture conditions Puri¢ed monocytes (2106 per ml) or isolated
dermal cell suspensions were incubated with RPMI 1640 supplemented
with 10% FBS and penicillin/streptomycin. EA or EAiC3b
(erythrocyte:monocyte or dermal cell ratio 25:1) were added in round-
bottomed tubes (Becton Dickinson Labware, Lincoln Park, NJ) and
incubated in a 5% CO2 incubator at 371C for 2 h. For monocytes, the
addition of human recombinant GM-CSF (Endogen,Woburn, MA) was
performed in some tubes and incubated for 40 h for CD40 staining, and
for 3 d for CD1c, CD14, CD80, CD86 staining. For anti-CD11b blocking
studies, cells were preincubated with puri¢ed heat-aggregated (for 30 min
at 651C) human IgG (2.5 mg per ml, Sigma) for 30 min at 41C, and then
with anti-CD11b (clone 44, BD Pharmingen, San Diego, CA, 100 mg per
ml) or isotype control (mouse IgG1, BD Pharmingen) for 30 min at 41C
before addition of sheep erythrocytes. For dermal cells, GM-CSF (500 U
per ml) was added and cells were incubated for 3 d. Prior to £ow
cytometry, sheep red blood cells were lyzed with lysis bu¡er (NH4Cl,
KHCO3) for 10 min on ice. For double color £ow cytometry, cells were
incubated with GM-CSF (500 U per ml) with or without IL-4 (50 U per
ml, Endogen) for 3 d. After sheep red blood cells were lyzed, cells were
further cultured with GM-CSF with or without IL-4 for an additional 3 d.
Flow cytometry The cells either from dermis or after culturing
were ¢rst incubated with puri¢ed heat-aggregated human IgG (2.5 mg
per ml, Sigma) for 30 min at 41C. Cells were then directly stained with
FITC-conjugated anti-CD14 (Caltag), FITC-conjugated anti-CD40
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(BD Pharmingen), phycoerythrin (PE) conjugated anti-CD80 (BD
Pharmingen), PE-conjugated anti-CD86 (Ancell Corporation, Bayport,
MN), or antigen-presenting-cell-conjugated anti-HLA-DR (Caltag), and
their appropriate isotypes were used as controls. For CD1c staining, the
cells were treated with primary mouse monoclonal antibody for CD1c
followed by FITC/PE-conjugated goat antimouse IgG1 secondary
antibody (Boehringer Mannheim, Indianapolis, IN; Caltag). For anti-
CD11b blocking study, the cells were stained with anti-CD1c antibody
(ICN Biomedicals, Aurora, OH) and PE-conjugated goat antimouse
IgG2a secondary antibody (Caltag). The stained cells were analyzed by
£ow cytometry usingWinList software (Verity Software House,Topsham,
ME). Data were expressed as percentage positive staining cells after
subtraction of cells in the same gate stained with isotype controls, or as
delta mean channel £uorescence intensity (dMFI). dMFI was calculated as
mean £uorescence of isotype staining subtracted from staining with
speci¢c antibody.
Cytokine enzyme-linked immunosorbent assay (ELISA) Cytokine
proteins in cell supernatant were quantitated by ELISAwith antibody pairs
for either IL-12 or IL-10 (Endogen). The sensitivity of all ELISAs was430
pg per ml.
Statistics Results were expressed as mean7standard error for n repeat
experiments. Statistical signi¢cance was determined by Student’s t test. A
p-value ofo0.05 was considered signi¢cant.
RESULTS
The time course of CD1cþ dermal DC disappearance/
reappearance after UV reveals an inverse correlation with
iC3b deposition The skin of normal human subjects was
exposed in vivo to UVB at various time points (0^10 d) prior to
biopsy, and frozen sections derived from this extended time
course were stained for both iC3b and CD1c.
We ¢rst examined iC3b deposition after UV, which we
hypothesized to be a regulator of CD1cþ dermal cells. The
results showed that iC3b deposits are increased in human skin in
the papillary dermis and along the dermal^epidermal junction on
day 3, and further demonstrated that iC3b deposits are faded on
day 7 and are back to normal by day 10 following UV exposure
(Fig 1A). By contrast, non-UV control skin lacked signi¢cant
iC3b deposits and isotype control staining was negative.
Meanwhile, we also examined whether the time course of
iC3b deposition correlated with the time course of reappearance
of CD1cþ dermal DC following UV exposure. As shown in
Fig 1(B), CD1cþ cells are prominent in the papillary dermis of
normal control skin. Even though this UV exposure protocol
induces a marked in¢ltration of monocytic cells between 6 h
and 3 d after exposure (Kang et al, 1998), 3 d after UV exposure
CD1cþ cells are exceedingly di⁄cult to visualize. It is not until
day 7 that CD1cþ cells are replenished in the papillary dermis,
concordant with the time course of disappearance of iC3b in
this microanatomic area.
To quantitate these ¢ndings, £ow cytometry was performed
on dermal cells isolated from keratomes from non-UV skin, and
skin at days 3, 7, and 10 following UV exposure. Consistent with
the immunostaining results, the percentage of CD1cþ cells in a
representative subject’s dermal cell suspensions was reduced from
5.5% in normal control skin to 2.1% on day 3, and recovered to
4.7% on day 7 and 8.2% on day 10 following UV exposure
(Fig 2A), after subtracting the matching isotype controls.
Aggregated data from four separate individuals (Fig 2B)
demonstrated that the reduction of dermal CD1cþ cells on day
3 (1.6%70.9%) was statistically signi¢cant compared with non-
UV skin (4.3%70.9%, p¼ 0.01). The reappearance of CD1cþ
dermal cells at day 7 (5.2%71.6%, p¼ 0.036) and day 10
(7.6%71.2%, p¼ 0.008) was also statistically signi¢cant relative
to day 3. In addition, when gated on HLA-DRþ cells, the
percentage of CD1cþ cells showed the same pattern of the time
course with a higher percentage (non-UV, 23.1%74.9%; day 3,
6.7%71.8%; day 7, 23.1%78.8%; day 10, 35.5%73.4%).
Thus, despite the presence of numerous monocytic cells in the
dermis after UV, CD1cþ dermal DC recovery from depletion in
the papillary dermal^epidermal junction area is spatially and
temporally correlated to the reciprocally regulated iC3b
deposition in this microanatomic location following UV
exposure.
Dermal cells from a keratome biopsy showed that iC3b
inhibits CD1c-expressing HLA-DRþ cells We hypothesized
that iC3b in the papillary dermis was modifying the monocytic
immigrants in the dermis from di¡erentiating into CD1cþ DC.
Dermal cell suspensions were isolated from keratomes 6 h after
UVB exposure, when in¢ltration of monocytic precursors has
begun but iC3b deposits have barely appeared (Kang et al, 1998;
Yoshida et al, 1998). The cells were incubated with EA or EAiC3b
Figure1. Time course of iC3b deposition and CD1cþ dermal den-
dritic APC disappearance/reappearance reveals an inverse correla-
tion. (A) Fluorescence immunostaining of skin biopsies. Non-UV skin
(a), and skin taken at day 3 (b), day 7 (c), and day 10 (d) following UV ex-
posure.White arrowheads show the dermal^epidermal junction (a, c, d).White
arrows show iC3b deposits at the dermal^epidermal junction. Scale bar: 10
mm. n¼ 2. (B) Non-UV skin (a), and skin taken at day 3 (b) and day 7 (c)
following UVexposure were stained with anti-CD1c monoclonal antibody
or its isotype control (day 3, d). Black arrows show CD1cþ cells. Dermal
CD1cþ cells were depleted on day 3, and recovered to normal levels by
day 7 following UV exposure. Scale bar: 40 mm.
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in the presence of the CD1c inducer GM-CSF for 3 d, and
analyzed by £ow cytometry. Incubation with EAiC3b
diminished the percentage of CD1cþ cells on HLA-DRþ cells
relative to the EA control in two out of two subjects. A
representative experiment is shown in Fig 3. The mean change
of CD1cþ cells in EAiC3b relative to EA was 17%. These
data suggested that iC3b can a¡ect dermal monocytic cell
di¡erentiation into CD1cþ precursor cells.
iC3b inhibits upregulation of CD1c on monocytic
precursors of DC and macrophage via a CD11b-dependent
mechanism The complexity of the mixture of cells in human
dermis and yield limitations prompted us to model monocyte
immigrant responses using blood monocytes. Because GM-CSF
is e¡ective in inducing CD1c and downregulating CD14 on
monocytes (Kasinrerk et al, 1993), we have used iC3b along with
short-term exposure to GM-CSF to explore the e¡ect of iC3b on
monocytes undergoing di¡erentiation to DC precursors as
measured by the CD1c di¡erentiation marker. As shown in
Fig 4(a), the addition of GM-CSF resulted in upregulation of
CD1c expression (Fig 4a, top panel vs second panel) whether
expressed as dMFI (51.076.4) or as percentage of CD1cþ cells
(63.3%79.3%; Fig 4b) (n¼ 6 subjects). In contrast, monocytes
cultured without GM-CSF minimally expressed CD1c, either as
dMFI (6.672.4; Fig 4a, top panel), or as a percentage of CD1cþ
cells (4.6%73.1%; Fig 4b). This upregulation of CD1c was
comparable to the results when the cells were incubated with
EA (Fig 4a, third panel) (dMFI¼ 42.775.1; 59.3%78.8%
positive; Fig 4b). In contrast, when cultured with EAiC3b in the
presence of GM-CSF, CD1c expression and the percentage of
CD1cþ cells were markedly downregulated (Fig 4a, bottom
panel) (dMFI¼17.673.8; 28.4%78.5%; Fig 4b). There was no
di¡erence in yield of cells between EA and EAiC3b.
To verify whether this e¡ect is iC3b^complement receptor type
3 ligation speci¢c, we performed antibody blocking studies using
anti-CD11b antibody, clone 44, in which the antibody binding site
overlaps with that of iC3b (Zhang and Plow, 1999). A preliminary
experiment con¢rmed that clone 44 blocked rosette formation of
monocytes with EAiC3b (80% inhibition, data not shown).
Monocytes were preincubated with clone 44 or isotype control
antibody, followed by incubation for 3 d with EA or EAiC3b in
the presence of GM-CSF. As shown in Fig 4(c), pretreatment with
clone 44 restored CD1c expression inhibited by iC3b, indicating
that the e¡ect of iC3b on DC di¡erentiation is speci¢cally
inhibited by antibody to its receptor on monocytes, CD11b.
iC3b di¡erentiates monocytes in vitro to a CD1c^CD14þ/^
non-DC monocytic population, which retains the capacity
to mature into CD1cþ DC upon IL-4 stimulation Double
color £ow cytometry has been employed to further analyze the
transitional di¡erentiation of monocytes under the in£uence of
cytokines and iC3b. The results revealed that incubation of
monocytes (93.1% CD1c^CD14þ ; Fig 5, left panel) with GM-
CSF induced maturation of cells expressing the CD1c DC
marker and lacking the CD14 macrophage marker (59.8%
CD1cþCD14^; Fig 5, lower middle panel). Exposure to iC3b
blocked the maturation of CD1cþCD14^ cells to 39.9% (Fig 5,
upper middle panel). Exposure to iC3b also blocked the appearance
of CD1cþCD14þ cells, another dermal dendritic APC pheno-
type, from 26.3% to 16.2% (Fig 5, middle panels). Conversely,
iC3b induced an almost 4-fold increase in cells expressing a
monocytic/macrophagic non-DC phenotype (CD1c^CD14þ)
from 3.3% to 14.1% (Fig 5, middle panels).
We next asked whether the CD1c^CD14þ /^ population, which
was expanded by iC3b exposure, is di¡erentiated to the point
where DC di¡erentiation is no longer possible, or whether these
Figure 2. Time course of the percentage of dermal CD1cþ cells fol-
lowing UVexposure determined by £ow cytometry. (A) Representa-
tive £ow diagrams of CD1c expression on dermal cells. Dermal cell
suspensions were isolated from keratomes taken at 3, 7, and 10 d after UV
exposure or from keratomes of non-UV-exposed skin. Cells were stained
with anti-CD1c monoclonal antibody or with the isotype-speci¢c controls
and analyzed by £ow cytometry. Percentages of stained cells after subtract-
ing the isotype background are given for the circles. (B) Results are ex-
pressed as the mean percentage of CD1cþ cells 7SEM. np-values are
0.01, 0.036, 0.008, respectively, for day 3 compared with non-UV, day 7,
and day 10 (paired t test) (n¼ 4 subjects).
Figure 3. iC3b inhibits CD1c expression on HLA-DRþ dermal
cells. Isolated dermal cell suspensions from skin, 6 h post-UV exposure to
stimulate an early in£ux of monocytes in vivo, were incubated with EA or
EAiC3b (erythrocyte:dermal cell ratio 25:1) for 2 h, followed by incubation
with GM-CSF (500 U per ml) for 3 d. Cells were analyzed by £ow cyto-
metry. A representative experiment demonstrating the percentage of
CD1cþ cells on HLA-DRþ cells after subtracting the isotype background
is shown within the gated areas.
INHIBITION OF CD1cþ CELLS BY UV-INDUCED iC3B 805VOL. 120, NO. 5 MAY 2003
cells are only temporarily blocked and still contain DC precursor
capabilities. Because IL-4 has been shown to di¡erentiate
monocytes more e¡ectively into DC together with GM-CSF
(Pickl et al, 1996; Palucka et al, 1998), we used IL-4 as a DC
di¡erentiation signal that could model intracutaneous signals
in vivo (i.e., mast cell IL-4) that result in DC recovery after
iC3b deposition wanes after UV. Indeed, IL-4þGM-CSF
di¡erentiated almost the entire population of iC3b-induced
CD1c^ cells into CD1cþCD14^ cells (91.7%; Fig 5, right upper
panel). These cells morphologically expressed dendrites under
microscopy. By contrast, iC3b-pre-exposed cells cultured
without the IL-4 DC signal, but only continued in GM-CSF,
maintained large numbers of CD1c^ cells, both CD14þ and
CD14^ (11.9%, 44.0%, respectively; Fig 5, right lower panel), and
did not recover the level of CD1cþ cells that were induced by
GM-CSF without iC3b at the onset of culture (Fig 5, lower
middle panel).
Conversely, addition of IL-4þGM-CSF at the onset of
culture di¡erentiated most of the monocytic cells into a
CD1cþCD14^ population, whether exposed to either EA or
EAiC3b (EA vs EAiC3b, 92.1% vs 90.7%; data not shown).
Thus, iC3b interaction with monocytic precursors at an early
stage of DC di¡erentiation can result in an arrest of such
di¡erentiation, which can subsequently be rescued upon provision
of a strong DC-inducing signal. These data are extremely
consistent with the in vivo sequence of events in human dermis.
iC3b inhibits upregulation of the costimulatory molecules
CD40 and CD80 as well on monocytes cultured with
GM-CSF Because CD40 and B7 are important costimulatory
molecules involved in APC functioning (Linsley et al, 1990;
Cayabyab et al, 1994), and are upregulated during DC
di¡erentiation, we next extended our examination to the e¡ect
of iC3b on the expression of these costimulatory molecules by
monocytes. GM-CSF was used to upregulate expression of
monocyte CD40, CD80 (B7.1), and CD86 (B7.2), compared to
the freshly isolated monocytes (data not shown). In each
individual tested, monocytes incubated with EAiC3b in the
presence of GM-CSF consistently expressed lower levels of
CD80 relative to monocytes incubated with EAþGM-CSF
(percentage change in dMFI relative to GM-CSF alone for
EAiC3b versus EA was ^66.9%76.2% vs ^2.7%710.9%). For
CD40, percentage change in dMFI relative to GM-CSF alone for
EAiC3b versus EAwas ^28.1%78.4% vs ^9%73.6%. By contrast,
CD86 did not exhibit consistent regulation by EAiC3b (Fig 6).
Thus CD80 and CD86 are di¡erentially regulated by iC3b.
GM-CSF-induced monocytic cells treated with iC3b
produce decreased levels of IL-12 but increased levels of
IL-10 To explore if the iC3b-arrested GM-CSF-treated cells
are coordinately modi¢ed in their cytokine production, we
further investigated IL-12p70 and IL-10 by iC3b-treated
monocytes cultured with GM-CSF. Freshly puri¢ed monocytes
Medium 
alone
Medium 
alone
EA
EAiC3b
With 500
U/ml
GMCSF
isotype
CD1c
% of CD1c+ cells dMFI
EA 32 13.4
EAiC3b 19.1 7.6
EAiC3b+isotype 21.2 8.4
EAiC3b+anti-CD11bAb 30.1 11.9
% of CD1c+ cells dMFI
M   4.6+ 3.1    6.6+ 2.4  
M+ GMCSF 63.3+ 9.3 51.0+ 6.4  
M+EA+GMCSF 59.3+ 8.8  42.7+ 5.1  
M+EAiC3b 28.4+ 8.5*  17.6+ 3.8*  
CD1c
Co
un
t
(a)
(b)
(c)
Figure 4. Inhibition of CD1c expression on monocytes by iC3b;
reversal by anti-CD11b I region antibody. (a) Puri¢ed monocytes were
incubated with medium alone (M), EA, or EAiC3b (erythrocyte:mono-
cyte ratio 25:1) for 2 h, followed by incubation with or without GM-CSF
(500 U per ml) for 3 d. Cells were analyzed by £ow cytometry. Dark lines:
cells were stained with anti-CD1c monoclonal antibody and with second-
ary antibody. Light lines: cells were stained with mouse IgG1 isotype con-
trols and with secondary antibody. The y axis represents the number of
cells at a given £uorescence intensity (x axis). (b) Puri¢ed monocytes were
incubated as described in (a); data are expressed as the mean of the percen-
tage of CD1þ cells7SEM and dMFI7SEM of six separate experiments
from six individuals. npo0.05 vs MþGM-CSF or EAþGM-CSF. (c) EA:
GM-CSF-stimulated monocytes exposed to EA only. EAiC3b: GM-CSF-
stimulated monocytes exposed to iC3b on EA. EAiC3bþ isotype: Incu-
bation with human IgG for 30 min, then addition of mIgG1 isotype con-
trol antibody for 30 min, preceded by GM-CSF and iC3b exposure.
EAiC3bþ anti-CD11b Ab: Incubation with human IgG for 30 min,
then addition of anti-CD11b antibody (clone 44), preceded by GM-CSF
and iC3b exposure. Cells were analyzed by £ow cytometry using mIgG2a
anti-CD1c and PE-conjugated secondary antibody. Data for this subject are
expressed as both the percentage of CD1cþ cells in total cells and dMFI.
Figure 5. iC3b di¡erentiates monocytes to a CD1c^CD14þ/^ non-
DC myeloid population that retains capacity to mature into CD1cþ
DC upon IL-4 stimulation. Puri¢ed monocytes were incubated with
EA or EAiC3b (erythrocyte:monocyte ratio 25:1) for 2 h, followed by in-
cubation with GM-CSF (500 U per ml) for 3 d. In some tubes, cells were
further incubated with GM-CSF (500 U per ml) with or without IL-4 (50
U per ml) for a further 3 d. Cells were analyzed by £ow cytometry. Data
are displayed as two-parameter dot-blots (PE-CD1c, FITC-CD14). Markers
were set according to the isotype controls. n¼ 2.
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and EA- or EAiC3b-treated monocytes were cultured with GM-
CSF for 3 d. ELISA analysis showed that monocytes cultured
with GM-CSF (CD1c upregulated) and EA (control for
EAiC3b) produced signi¢cantly higher amounts of IL-12
(4717133 pg per ml, n¼ 4) relative to monocytic cells cultured
with EAiC3b (iC3b-regulated, CD1c-inhibited cells, 89713 pg
per ml) (p¼ 0.033) (Fig 7). Fresh monocytes stimulated with
interferon-gþ lipopolysaccharide served as a control (3667113
pg per ml). In contrast, although monocytes cultured with GM-
CSF produced IL-10, the amount was low; however, EAiC3b still
stimulated signi¢cantly higher IL-10 levels (187784 pg per ml)
relative to EA control (100732 pg per ml) (n¼ 4, p¼ 0.034).
Fresh monocytes stimulated with lipopolysaccharide served as a
positive control (1141739 pg per ml). These data indicate that
IL-12, a potent cytokine produced by human epidermal
Langerhans cells (Kang et al, 1996) and dermal CD1cþ DC
(Kang et al, 1998), is downregulated in monocytic precursor cells
by iC3b, in conjunction with arrest of the monocytic precursors’
ability to di¡erentiate into CD1cþCD14^ cells. In addition, even
in this precursor condition, iC3b still plays a role in inducing
IL-10, a reciprocal regulatory cytokine to IL-12.
DISCUSSION
UVB irradiation of human skin causes a shift in the dominant
APC population in the dermis from CD1þCD11bþ DC to
CD1^CD11bþ macrophages. This change has been largely ac-
counted for by both a rapid disappearance of CD1cþ DC and
new blood monocytes entering the dermis (Meunier et al, 1995).
The milieu encountered by the freshly immigrating monocytic
population probably plays a critical role in determining whether
precursor cells di¡erentiate into DC replacements for Langerhans
cells or into tissue macrophages. This study indicates that the de-
lay between in¢ltration beginning 6 h after UVexposure and the
day 7 reconstitution of CD1cþ DC in the dermis may be due to
the deposition of iC3b in the dermis at this time and its ability to
arrest DC di¡erentiation and promote CD1c^CD14þ macro-
phage phenotype expression.
We have shown that iC3b deposits are present in contiguity
with in¢ltrating monocytic/macrophagic cells in the dermal^epi-
dermal junction area shortly after UV exposure of human skin
(Yoshida et al, 1998). In this time course study, we show that
CD1cþ dermal DC remain downregulated whereas iC3b deposi-
tion is prominent in the skin following UV exposure (resolution
by day 7). Notably, upon full clearance of iC3b the percentage of
dermal CD1cþ cells rebounded at day 10 following UVexposure
relative to that of non-UV skin, followed by stabilization to nor-
mal levels at day 14 (Fig 2).
Because UV preferentially induces keratinocytes to produce
GM-CSF (Gallo et al, 1991), it is highly likely that blood mono-
cytes entering UV-damaged skin will be exposed to GM-CSF.
GM-CSF has been shown to expand DC APC in human dermis
in vivo (Kremer et al 2000) and to enhance myeloid-derived APC
function (Witmer-Pack et al, 1987; Fischer et al, 1988; Heu£er et al,
1988; Chantry et al, 1990). Furthermore, GM-CSF alone is able to
induce CD1molecules, a speci¢c marker for DC, and can down-
regulate CD14 on monocytes (Kasinrerk et al, 1993). The addition
of iC3b to the dermal cell suspensions with GM-CSF supplement
resulted in a lower percentage of CD1cþHLA-DRþ cells, com-
pared to the EA control (Fig 3). Although human dermal cells
contain a variety of monocytic cells and DC, even in this com-
plex mixture we were able to detect an e¡ect of iC3b in decreas-
ing the number of CD1cþ cells. This suggested that the use of
fresh peripheral blood monocytes to model newly immigrated
cells into UV-exposed skin would be a better model for this
study and is valid for the linking of in vitro studies and in vivo
dermal monocytic cells.
Indeed, in concordance with the dermal cell data, our in vitro
results with fresh human monocytes showed that addition of
GM-CSF to monocytes resulted in enhancement of
CD1þCD14^CD40þ cells (Figs 5, 6), which is comparable to
the phenotype of dermal DC/dermal APC in vivo (Nestle et al,
1993; Meunier et al, 1995). Moreover, these CD1cþ cells also de-
monstrated enhanced IL-12p70 production consistent with early
DC di¡erentiation and Langerhans cells (Kang et al, 1998). By
contrast, incubation with iC3b in the presence of GM-CSF in-
hibited CD1c expression and produced signi¢cantly decreased
levels of IL-12p70 production (Fig 7). Interestingly, in terms of
IL-10, a reciprocal regulatory cytokine to IL-12, iC3b still func-
tions to signi¢cantly induce IL-10 production by the GM-CSF-
treated, CD1c-upregulated monocytic precursors, implying that
the dichotomous phases of precursor cells are strongly a¡ected
by the iC3b molecule.
These ¢ndings are consistent with the decreased IL-12 produc-
tion by macrophage-colony-stimulating-factor-di¡erentiated macro-
phages (Smith et al, 1998), and with in vivo data demonstrating
that human skin macrophages present in UV-exposed skin exhi-
bit low IL-12 production (Kang et al, 1994; 1998).
DC maturation is also associated with upregulation of acces-
sory molecules such as CD40 and B7 on DC that are critically
involved in T cell activation and tolerance through the B7:CD28
and CD40:CD40L pathways (Howland et al 2000). Under the
conditions of our study, addition of GM-CSF to monocytic cells
clearly induced expression of CD40, CD80, and CD86 (Alderson
et al, 1993; Liu et al, 1999). Consistent with our hypothesis, incuba-
tion of monocytic cells with EAiC3b in the presence of
GM-CSF demonstrated the novel ¢nding that iC3b not only
Figure 6. iC3b di¡erentially regulates costimulatory molecules on
monocytes. Puri¢ed monocytes were incubated with medium alone
(M), EA, or EAiC3b (erythrocyte:monocyte ratio 25:1) for 2 h, followed
by incubation with GM-CSF (10 U per ml for CD40 staining, 500 U per
ml for CD80, CD86 staining). The cells were stained with anti-CD40
monoclonal antibody, anti-CD80 monoclonal antibody, anti-CD86 mono-
clonal antibody, or the matching isotype controls. Results are expressed as
percentage change in £uorescence intensity relative to M, after subtracting
the isotype controls. Each line represents di¡erent individuals.
Figure 7. GM-CSF-induced monocytic cells treated with iC3b pro-
duce decreased levels of IL-12 but increased levels of IL-10. Puri¢ed
monocytes were cultured as described for Fig 4 for 72 h. Freshly puri¢ed
monocytes stimulated with interferon-g 1 ng per mlþ lipopolysaccharide
1 ng per ml for IL-12 production served as controls. Supernatants were
then harvested for ELISA analysis. Results are expressed as picogram per
ml and as the mean7SE. n¼ 4. np¼ 0.033. nnp¼ 0.034.
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inhibited CD1c but CD40 and CD80 expression as well (Fig 6),
again suggesting that iC3b binding to b2 integrin on monocytes
arrests DC di¡erentiation, and involving molecules critical for in-
itiating immune responses. Because in vivo UV-induced macro-
phages harvested from the skin at the peak of iC3b deposition
are also low expressors of costimulatory molecules (Kremer et al,
1998), and inhibition of iC3b after UVB reverses immune sup-
pression and tolerance (Hammerberg et al, 1998), these processes
may be an important mechanism of UV immunoregulation.
These ¢ndings are also consistent with the in vivo data (Figs 1,
2) showing a temporal and spatial correlation between UV-in-
duced iC3b and the shifting APC populations in the dermis after
UVB irradiation.
Of interest is that iC3b di¡erentially regulated B7 molecules
on monocytic cells, in which B7.1, but not B7.2, expression was
blocked. These data are consistent with our in vivo observation
that UV macrophages are minimal for B7.1, but obviously posi-
tive for B7.2 (Kremer et al, 1998). Several studies have demon-
strated that B7.1 and B7.2 di¡er in their capacity to generate Th1
versusTh2 responses (Freeman et al, 1995; Kuchroo et al, 1995), sug-
gesting that an iC3b e¡ect on monocytes may favor a Th2 re-
sponse or at least diminish aTh1 response.
In summary, this study provides insight into the mechanism
behind the ¢nding that blockade of iC3b formation reverses the
UV-induced inhibition of contact hypersensitivity and delayed-
type hypersensitivity (Hammerberg et al, 1998). Thus, iC3b de-
posited in UV-exposed skin may actively participate in the pro-
longed but transient depletion of dendritic APC populations in
the dermis after UV exposure, and simultaneously promote
macrophage di¡erentiation of precursors in the newly immigrat-
ing monocytic populations. These ¢ndings may be relevant to
other conditions associated with complement activation, such as
occur in microbial infections. Thus, we propose that UV expo-
sure generates iC3b deposition and in¢ltration of monocytic cells
into the dermis, including CD1c^CD11bþ monocytic precursor
cells. CD11b recognition of iC3b then causes the precursor cells
to be transiently arrested in their ability to di¡erentiate into
CD1cþ DC, but to be promoted into CD1c^ macrophage di¡er-
entiation. Such macrophage di¡erentiation at this time may be
adaptively advantageous, allowing phagocytosis of UV-damaged
or infected cells and generation of antimicrobial reactive oxygen
species and nitric oxide. On the other hand, preexisting tissue
DC already expressing CD1c would be able, at least early on be-
fore depletion, to uptake and process tumor-initiated cell neoan-
tigens or microbial antigens, migrate to lymph nodes, and
activate antigen-speci¢c T cells. Following disappearance of
iC3b, monocytic precursor cells are hypothesized to be able to
begin to di¡erentiate into CD1cþ DC again, based upon in vivo
observations (Figs 1, 2) and our in vitro observations (Fig 5). Ta-
ken together, the critical nature of iC3b and CD11b interactions
in UV-induced immune suppression may be due to the ability of
iC3b to transiently arrest monocytic DC precursor di¡erentiation
while simultaneously allowing or promoting macrophage di¡er-
entiation in the skin.
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